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INTRODUCTION
           Autonomic nervous system involvement in diabetes mellitus was described by 
Rundles in 1945.   The study of autonomic nervous system involvement in diabetes 
mellitus is of special interest because this appears to have increased mortality. About 50 
% of patients with autonomic dysfunction of five years duration die of sudden cardio 
respiratory arrest 
              In 20 to 40% of all diabetes mellitus patients some   abnormalities of autonomic 
function is present. Diabetic autonomic neuropathy can involve both sympathetic and 
parasympathetic  nervous  system.  Parasympathetic  abnormalities  appear  earlier  and 
sympathetic innervations may remain intact even in presence of severe Parasympathetic 
damage.  
              Abnormalities in bowel and bladder function and impotence has been ascribed 
to involvement of autonomic nervous system in diabetes mellitus
           The integrity of autonomic nervous system can be assessed with several simple 
tests  which  are  based  on  cardiovascular  reflexes.  These  tests  are  dependent  on  the 
response of heart rate and blood pressure to a variety of stimuli.
Autonomic function test reflecting parasympathetic function 
1  Heart rate response to Valsalva maneuver 
2  Heart rate variation during deep breathing
3  Immediate heart rate response to standing
Autonomic function test reflecting sympathetic function
1  Blood pressure response to standing
2  Blood pressure response to sustained hand grip
3 These results are correlated to duration of disease and with age of patient. 
     
AIMS OF STUDY
    
 To determine various aspect of autonomic neuropathy in diabetic population 
using series of standardized test.
 To interpret the different type of presentation of autonomic neuropathy in 
diabetes mellitus 
 To  study  the  clinical  presentation  of  autonomic  neuropathy  in  diabetes 
mellitus
REVIEW OF LITERATURE
           Diabetes mellitus is defined as a group of common metabolic disorders that share  
the  phenotype  of  hyperglycemia.  The  factors  contributing  to  hyperglycemia  include 
reduced insulin secretion, insulin resistance, decreased glucose utilization and increased 
glucose  production.  Diabetes  mellitus  is  caused  by  complex  interaction  of  genetics, 
environmental factors and life style choices (1). The disease has particular predilection 
for micro vascular complications and tendency for macro vascular complication. Hence 
diabetes is a metabolic cum vascular disease.  
        Historical background of understanding of diabetes can be traced as early as third 
century B.C. The Ebers papyrus written about 1550 B.C, the prescription to drive away 
the passing too much urine recommends bones, wheat grains, green lead earth and water. 
The ancient physicians recorded the observation that if too many ants swarm around 
spot of urine if the person is diabetic (2).
    Two  Greek  physicians  Galen  and  Arateus2 of  Cappadocia  in  
130  –  201  A.D  classified  acute  and  chronic  diseases.  They  described  meaning  of 
diabetes  as  siphon  liquefaction  of  flesh  and  bones  in  
urine.
           Ancient Hindu document by Susrutha2 in India in 400 BC described diabetic 
syndrome characterized by honeyed urine.
           Langerhans (1869) discovered ilets  which was later  named as  islets  of 
Langerhans.  In  1893  he  suggested  that  collection  of  interacinar  cells  as  gland  of 
secretion within the pancreas.2
           Jean-de-meyer (1910)2 suggested that  the pancreatic secretion lacking in 
diabetes be called insulin to denote the origin from insulae on langerhans.
           In 1921-22 Fredrick Banting surgeon,  John Macleod physiology professor, 
Charles  Best  graduate  and  J.b.Collip  skilled  chemist  fulfilled  all  criteria  by 
demonstrating  therapeutically  active  insulin  preparation  for  treatment  of  diabetes 
mellitus.2
Classification of diabetes mellitus1
  Type 1 diabetes  due to absolute insulin deficiency (beta cell destruction)
  Type 2 diabetes range from predominantly  insulin  resistance with relative 
insulin deficiency to predominantly insulin secretory defect with insulin resistance (1).
  Other specific types of diabetes
A. Genetic defect of beta cell function characterized by mutation
1. Hepatocyte nuclear transcription factor (MODY 1)
2. Glucokinase (MODY 2)  
3. HNF-1 α ( MODY 3)  
4. Insulin promoter factor (MODY 4)
5. HNF-1 β ( MODY 5)  
6. Neuro D1 (MODY 6)
7. Mitochondrial DNA
8. Proinsulin or insulin conversion
B. Genetic defect in insulin action
1. Type A insulin resistance
2. Leprechaunism
3. Rabson-mendenhall syndrome
4. Lipodystrophy syndromes
C. Diseases of exocrine pancreas
1. Pancreatitis 
2. Pancreatectomy
3. Cystic fibrosis 
4. Hemochromatosis 
5. Fibrocalculus pancreatopathy
D. Endocrinopathies
1. Acromegaly 
2. Cushing’s syndrome
3. Glucagonoma
4. Pheochromocytoma
5. Hyperthyroidism
6. Somatostatinoma
7. Aldosteronoma
E. Drug induced
1. Pentaminidine
2. Glucocorticoids
3. Nicotinic acid
4. Thyroid hormone
5. Beta adrenergic agonists
6. Thiazides
7. Beta blockers
8. Phenytoin
F. Infections
1. Congenital rubella
2. Cytomegalovirus
3. Coxsackie virus
G. Immune mediated diabetes
1. Stiff-man syndrome
2. Anti-insulin receptor antibodies
H. Genetic syndrome associated with diabetes
1. Down’s syndrome
2. Klinefelter’s syndrome
3. Turner’s syndrome
4. Wolfram s syndrome
5. Prader-willi syndrome
6. Myotonic dystrophy
 Gestational diabetes mellitus 
DIAGNOSTIC CRITERIA
I. Random plasma glucose or more than equal to 200mg/dl (11 mmol/dl) with 
classic symptoms polyuria, polydipsia, and weight loss.1
II. Fasting plasma glucose (no caloric intake for at least 8 hours) more than or 
equal to 126mg/dl (7 mmol/dl)
III. 2 hour plasma glucose during oral glucose tolerance test more than or equal 
to 200mg/dl (11 mmol/dl) 
Classification of diabetic neuropathy1
1. Somatic
• Polyneuropathy 
• Polyradiculopathy
• Mononeuropathy
• Mononeuropathy multiplex
2. Visceral – autonomic neuropathy
• Cardiovascular 
• Gastrointestinal  
• Sudomotor    
• Genitourinary   
• Hypoglycemia unawareness                                         
POLYNEUROPATHY 
             Polyneuropathy is predominantly sensory. Clinical features are hyperesthesia, 
paresthesia, dysesthesia, numbness, tingling sensation, burning that begins in feet and 
spreads proximally, bilateral glove and stoking loss of sensation, diminished vibration 
sense, absent ankle jerk, abnormal position sense and ulceration over ball of the foot.
POLYRADICULOPATHY 
             Polyradiculopathy involves one or more nerve roots causing severe disabling  
pain with motor weakness. Intercostal or truncal radiculopathy causes pain over thorax 
or abdomen. 
MONONEUROPATHY
          This includes dysfunction of isolated cranial nerve or peripheral nerve. Clinically 
patient presents with pain or weakness in distribution of single nerve.   
 Trochlear  (fourth)  or  abducens  (sixth)  -  Ptosis  and 
opthalmoplegia
 Facial nerve (seventh cranial nerve)    -   Bells palsy 
MONONEUROPATHY MULTIPLEX
              Subacute affection of multiple nerves simultaneously leads to mononeuritis 
multiplex .6
Causes
 Diabetes
 Polyarteritis nodosa
 Chrug strauss syndrome
 Lymes disease
 Leprosy
 Cryoglobulinemia
DIABETIC AMYOTROPY 
Involvement of lumbar plexus or femoral nerve causes pain in thigh or hip and is 
associated with muscle weakness in hip flexors or extensors. 
Functional Organization of Autonomic Nervous System6
The Autonomic nervous system is an efferent system that innervates vascular and 
visceral smooth muscle, exocrine and endocrine glands, parenchymal cells throughout 
the various organ systems in the body. The distribution of blood flow and maintenance 
of tissue perfusion, regulation of volume and composition of extra cellular fluid, the 
expenditure of  metabolic energy and supply of substrate and the activity of visceral 
smooth muscle glands.
Anatomic Organization of Autonomic Nervous System
             The Autonomic nervous system is located in ganglia outside central nervous 
system give rise to postganglionic autonomic nerves that innervates organs and tissue 
throughout the body.
Afferent Autonomic Nervous System
Sympathetic  Nervous  System: Terminate  in  spinal  cord  in  intermediate  zone  grey 
matter in relation to preganglionic neurons
 Function :  Important in appreciation of visceral pain.
Parasympathetic  Nervous  System :   afferent  fibers  from mouth  and  pharynx  and 
respiratory, cardiac and gastrointestinal system, terminate in nucleus of tractus solitarius 
through facial, glossopharyngeal and vagus nerve.
  Function :  important in maintaining the visceral reflexes. 
      Autonomic nervous system maintains the visceral and homeostatic function essential  
to life.  Both sympathetic and parasympathetic system is regulated by limbic system, 
hypothalamus,  and  ventricular  formation.  Fibers  from  these  structures  descend  to 
synapse with preganglionic neurons in intermediolateral column T1 to L2 (Sympathetic - 
thoracolumbar).
         Cranial  nuclei  occulomotor,  facial,  glossopharyngeal,  vagus,  and  S2-S4 
(Parasympathetic - craniosacral)
NEUROTRANSMITTER 
               Acetylcholine is preganglionic neurotransmitter for both division of autonomic  
nervous  system  as  well  as  postganglionic  neurotransmitter  of  the  parasympathetic 
system. Cholinergic neuron also supplies sweat glands (eccrine), and some blood vessel 
supplying skeletal muscle.
      DIRECT EFFECT
            Catecholamines on cardiovascular system stimulate vasoconstriction in the 
subcutaneous,  mucosal,  splanchnic,  and  renal  vascular  beds  by  an  alpha  receptor 
mediated mechanism
           Catecholamines influence the secretion of variety of hormones including renin,  
insulin,  glucogon,  cacitonin,  parathormone,  thyroxine,  gastrin,  erythropoietin, 
progesterone, and testosterone.
 PHYSIOLOGY OF AUTONOMIC NERVOUS SYSTEM 
Autonomic neuropathy pain
 Gate theory of pain (melzack and wall) proposed that interneuron’s in substantia 
gelatinosa  of  spinal  cord  exerts  a  modulating  effect  upon  sensory  input  before  this 
activates the first  central transmission cells in dorsal horn of the cord which in turn 
stimulates central mechanism responsible for response and perception. Tonic activity in 
small  C  fibers  keep  open the  gate  and allow the  transmission  of  painful  sensation, 
activity in A fibers tends to close the gate. Perception of pain depends upon relative 
activity in large and small fibers. Counterirritant as by scratching or rubbing increase 
large fiber discharge and reduces pain.
PHYSIOLOGY OF VALSALVA MANEUVER
There are important effects of respiration on the heart and circulatory system.
In central nervous system there are interactions between respiratory pacemakers 
and efferent autonomic tone which directly affect heart rate and blood pressure.
These pacemakers induce variation in systemic blood pressure at same period as 
the frequency of respiration. These blood pressure waves termed as Traube - Hering 
waves, who explained it.5
During inspiration the pacemaker waves stimulates efferent sympathetic nerve.
Vagal  tone  is  also  centrally  mediated  and  related  to  respiration.  Vagal  tone 
decreases during expiration and increases during inspiration through baroreceptors and 
stretch receptors.
      Mechanically during inspiration intrathoracic pressure is reduced which results in 
increased right atrial inflow. Left atrial inflow is transiently reduced consequent to rise 
in  pulmonary  vascular  capacity  leading  to  fall  in  aortic  blood  pressure  in  early 
inspiration.
  During expiration systemic venous return reaches the left atrium which increases 
left  ventricular  outflow,  results  in  an  increase  in  systemic  pressure  retuning  blood 
pressure to its peak level.
         During inspiration heart rate increases due to central factors and brain bridge  
effect. Heart rate is reduced in late inspiration and early expiration.
CARDIOVASCULAR SYSTEM
          Parasympathetic effects of heart are mediated by vagus nerve. Acetylcholine 
reduces rate of spontaneous depolarization of sinus node and reduces the heart rate.
        GASTROINTESTINAL TRACT
Parasympathetic innervation of gut is via vagus nerve and the pelvic sacral nerve. 
The  parasympathetic  nervous  system  increases  the  tone  of  gastrointestinal  smooth 
muscle, increases peristaltic activity and relaxes gastrointestinal sphincter. The classic 
concept  of  diabetic  diarrhea  is  nocturnal  diarrhea  or  incontinence  of  feces  in  night 
without  knowledge  to  patient.  The  mechanism  of  diabetic  diarrhea  has  not  been 
established. The possibilities are;
 Autonomic neuropathy
 Bacterial overgrowth in stomach and small intestine
 Pancreatic exocrine dysfunction
 Intestinal muscular abnormalities
ORTHOSTATIC HYPOTENSION 
Standing up results in pooling of blood in dependant part of body due to effect’s 
of  gravity.  Sympathotonic  hypotension  rare  form  of  orthostatic  hypotension  of 
neurogenic  origin  associated  with  marked  tachycardia  when  patient  stands.  The 
sympathetic nervous system seems to react normally to postural changes, but there is 
impaired response of the effect or organ to nor epinephrine causing a drop in blood 
pressure despite the increased pulse rate
NEUROGENIC BLADDER 
           There is reduced frequency in juvenile diabetics with vesical involvement (of  
autonomic neuropathy) due to increased bladder capacity.
IMPOTENCE 
Impotence  is  neuropathic  manifestation  of  diabetes.  In  survey  
of  200  diabetics,  neurogenic  bladder  as  a  result  of  autonomic  
neuropathy  has  strongly  association  with  impotence.  Libido  persists  initially,  but  in 
some tends to decrease while in others it may not diminish for years.
           Other neurological disorder may also be responsible for impotence with retention 
of  libido.  A  disease  affecting  the  spinal  cord  or  with  local  involvement  of 
parasympathetic plexus prevents the reflex or erection. Some of these are tabes dorsalis, 
syringomyelia, multiple sclerosis, spinal cord tumors, Pernicious anemia and myelitis. 
Vascular disorders such as thrombosis of aortic bifurcation or arteriosclerosis may cause 
impotence.
           The equivalent of erectile failure in women is absence of vaginal lubrication 
during intercourse. A distinct entity clitoral neuropathy has been reported. This is usually 
mistaken for candidal vaginitis, since it produces Paresthesias over genitalia. Adequate 
control of diabetes and prompt treatment of candidal vaginitis relieves dyspareunia and 
orgasmic dysfunction. 
PATHOPHYSIOLOGY OF PERIPHERAL NEUROPATHY
 Myelin sheath is most susceptible element. 
 Axonal degeneration occurs due to repeated demyelination and remyelination 
which leads to onion bulb formation of schwan cells and fibroblast.
 Lesions are found in posterior column of spinal cord posterior roots, rami 
communicants and sympathetic ganglia.
 Basement membrane of intraneural capillaries are thickened and duplicated 
(6).
PATHOPHYSIOLOGY OF AUTONOMIC NEUROPATHY
Hyperglycemia
Increased sorbitol and fructose
Decreases myoinositol in schwan cells and axons
Decreased phosphoinositol turn over
Decreased sodium potassium ATPase activity
Abnormal energy metabolism
Nerve dysfunction
         
CLINICAL FEATURES OF AUTONOMIC NEUROPATHY 
Autonomic nervous system abnormalities can affect  a variety of system in the 
body.
CARDIOVASCULAR SYSTEM 
Autonomic  neuropathy  of  cardiovascular  system  causes  postural  hypotension, 
resting tachycardia, loss of heart rate variation, and sudden cardio respiratory arrest.
GASTROINTESTINAL
              Autonomic neuropathy of gastrointestinal system causes
 Nocturnal diarrhea due to gastroparesis
 Abdominal fullness due to gastric atony
 Dysphagia due to esophageal atony
UROGENITAL
 Urinary incontinence, recurrent infection due to atonic bladder
 Impotence, retrograde ejaculation, loss of testicular sensation 
RESPIRATORY SYSTEM – Respiratory Arrest
Pupilary abnormalities
Autonomic  neuropathy  causes  reduced  resting  diameter,  delayed  or  absence 
response to light, resistance to mydriatics, and diminished hippus.
VASOMOTOR 
    Loss of skin vasomotor responses
• Peripheral vascular changes
• Charcot’s arthropathy
       Dependent oedema
SUDOMOTOR 
 Hyperhydrosis  of  upper  extremities  and    anhydrosis  of  lower 
extremities
 Gustatory sweating
 Nocturnal sweats without hypoglycemia
 Fissures in the feet
  HYPOGLYCEMIC UNAWARENESS
 Decreased  catecholamine  release  with  loss  of  warning  symptoms  of 
hypoglycemia 
 Decreased pancreatic glucagon and pancreatic polypeptide release
CAUSES OF AUTONOMIC DYSFUNCTION
             The causes of autonomic dysfunction are many some of the common causes are  
listed below (1).
I.  AUTONOMIC DISORDERS WITH BRAIN INVOLVEMENT
A. Associated with multisystem degeneration
1. Multisystem degeneration: autonomic failure clinically Prominent
a) Multisystem atrophy
b) Parkinsons disease with autonomic failure
c) Diffuse lewy body disease
2. Multisystem degeneration: autonomic failure clinically not Prominent
a) Parkinsons disease
b) Other extrapyramidal disease
i. Spinocerebellar atrophies
ii. Machado-joseph disease
iii. Progressive supranuclear palsy
iv. Corticobasal degeneration
B. Unassociated with multisystem degeneration
1. Disorders mainly due to cerebral cortex involvement
a) Frontal cortex lesion
b) Complex partial seizures
2. Disorders of limbic and paralimbic circuits
a) Shapiro’s  syndrome  corpus  callosum  agenesis,  hyperhydrosis  and 
hypothermia
b) Autonomic seizures
3. Disorders of hypothalamus
a) Wernicke-korasakoff syndrome
b) Diencephalic syndrome
c) Neuroleptic malignant syndrome
d) Serotonin syndrome
e) Antidiuretic  hormone  syndromes  (diabetes  insipidus,  inappropriate 
ADH)
f) Fatal familial insomnia
g) Disturbance of appetite
h) Disturbance of sexual function
i) Disturbances of gastric function
j) Horner’s syndrome
4. Disorders of brainstem and cerebellum
a) Posterior fossa tumors
b) Syringobulbia and arnoldchiari malformation
c) Cardiac arrhythmias
d) Central sleep apnea
e) Baroreflex failure
II. AUTONOMIC DISORDERS WITH SPINAL CORD INVOLVEMENT
a) Traumatic tetraplegia
b) Syringomyelia
c) Subacute combined degeneration
d) Multiple sclerosis
e) Amyotrophic lateral sclerosis
f) Tetanus
g) Stiff-man syndrome
h) Spinal cord tumors
III. AUTONOMIC NEUROPATHIES
A. Acute/subacute autonomic neuropathies
Subacute autonomic neuropathy
a) Subacute paraneoplastic autonomic neuropathy
b) Gullian-barre syndrome
c) Botulism
d) Porphyria
e) Drug induced autonomic neuropathies
f) Toxic autonomic neuropathies
B. Chronic peripheral autonomic neuropathies
1. Distal small fiber neuropathy
2. Combined sympathetic and parasympathetic failure
a) Amyloid
b) Diabetic autonomic neuropathy
c) Autoimmune autonomic neuropathy
d) Sensory autonomic neuropathy
e) Familial dysautonomia (Riley-Day syndrome)
MANAGEMENT OF AUTONOMIC DYSFUNCTION IN DIABETES MELLITUS
1. Management of Postural hypotension1
Non-pharmacologic approach
1. High-salt diet (10 to 20 grams per day)
2. High fluid intake (2 liters per day)
3. Elevate head of bed 4 inches
4. Compression garments – Elastic stockings
5. Correct anemia
6. Patient education of mechanism
a) Volume status
b) Resistance
c) Capacitance bed
d) Autoregulation 
7. Patient education of stressors of orthostatic hypotension 
a) Influence of meals
b) Standing
c) Exercise
d) Heat
e) To  sit  with  legs  dangling  over  the  edge  of  bed  for  several 
minutes before attempt to stand in the morning.
8. To learn physical counter maneuvers
a) To  maintain  contraction  of  leg  muscle  for  
30 seconds
b) Leg crossing
Such maneuvers compress leg veins and increase systemic resistance
PHARMACOLOGIC TREATMENT 1
1) Midodrine – alpha agonist 5 to 10 mg thrice daily
Some patients respond best to decremental dose like 15 mg on awakening, 10 mg 
at noon and 5 mg in the afternoon. It should not be given after 6 P.M.  Side effects are 
Pruritis, uncomfortable piloerection and supine hypertension.
2) Fludrocortisone – 0.1 to 0.3 mg per day in two divided doses
                 It enhances renal sodium conservation and increases the sensitivity of  
arterioles to nor epinephrine. Side effects are Supine hypertension and hypokalemia.
3) Pyridostigmine 
                 It improves orthostatic hypotension without causing supine hypertension by  
enhancing ganglionic transmission maximum during orthostatic and minimum in supine 
position.
MANAGEMENT OF POSTPRANDIAL HYPOTENSION1
Frequent  small  low-carbohydrate  meals  may  diminish  splanchnic  shunting  of 
blood after meals
      Prostaglandin inhibitors – ibuprofen or indomethacin
Midodrine                      – 10mg along with meals
Octreotide - (25µg  twice  daily  to  200µg  thrice  daily) 
somatostatin  analogue  inhibits  the  release  of 
gastrointestinal peptides. (Gastrointestinal peptide 
is vasodilator which will cause hypotension).
MANAGEMENT OF GASTROINTESTINAL DYSFUNCTION
Good glycemic control will improve gastric function and autonomic neuropathy
Smaller, more frequent meals, fiber rich, easier to digest, low in fat, will minimize 
symptoms of gastroparesis
Drugs for gastroparesis
a) Cisapride 10 to 20mg before each meal 
b) Bethanechol 10 to 20 mg before each meal
c) Dopamine agonist domperidone 10 to 20 mg or metaclopramide 5 to 10 mg 
before each meal.
Diabetic diarrhea 
In absence of bacterial growth, can be treated with
a) Loperamide
b) Octreotide 50 to 75 µg thrice daily subcutaneously
c) Clonidine at higher doses 0.6 mg thrice daily
MANAGEMENT OF BLADDER DYSFUNCTION AND URINARY RETENTION
Bladder  emptying  is  improved  with  cholinergic  agonist  Bethanechol  (reduces 
residual urine) and phenoxybenzamine. Bladder neck surgery to minimize the urethral 
resistance 
MANAGEMENT OF IMPOTENCE
a) Injection  of  papaverin  40  to  80  mg  directly  into  corpus  cavernosum 
improves neuropathic impotence.
b) Vasculogenic impotence due to small vessel disease needs bypass surgery 
which relieves proximal vessel occlusion.
c) Semi rigid or malleable prosthesis and inflatable prosthesis are available.
d) Recently ‘Erect aid systems’ with vacuum fitting have found a high degree 
of patient acceptance.  
e) Lubricants like K.Y jelly during intercourse helps overcome dry coitus.
CARDIO RESPIRATORY ARREST
Sudden and unexpected deaths occur in diabetics with autonomic neuropathy this 
may be due to cardio respiratory arrest in association with hypoxia. any diabetics who 
has autonomic neuropathy is  a considerable  anesthetic risk and particular  care to be 
taken during and after the operation to try to prevent such episodes, which may be due to 
sudden changes in inspired oxygen saturation. 
PREVENTION OR REVERSAL OF AUTONOMIC DAMAGE
By  the  time  the  symptoms  developed  autonomic  nerve  damage  is  probably 
irreversible and carries poor prognosis. 
a) Good  metabolic  control  can  achieve  some  reversal  of  autonomic 
abnormalities.
b) Aldose reductase inhibitors sorbinil  or epalrestat  250 mg daily improves 
pain numbness, and motor nerve conduction velocity.
c) Myoionositol rich in sea food and vegetables like drumstick can achieve 
some reversal of autonomic damage. 
METHODS OF TESTING AUTONOMIC DYSFUNCTION
Ewing-et-al  (1978) proposed five simple tests to assess autonomic neuropathy 
based on cardiovascular reflexes. These are
1. Valsalva maneuver 
2. Heart rate variation to deep breathing
3. Heart rate response to standing
4. Postural variation of blood pressure
5. Hand grip test (In normal person diastolic blood pressure variation > 
16mm)
The first  three test  assess cardiac parasympathetic  function and last  two test  mainly 
sympathetic function
1. Valsalva maneuver 
It consists of forced expiration against closed glottis. This procedure by producing 
a rise in intrathoracic pressure causes acute drop in effective filling pressure of the heart 
with consequent changes in stroke volume (5). 
CLINICAL PROCEDURE 
First  resting  electrocardiogram is  recorded.  The  procedure  is  explained  to  the 
patient who is trained to blow and maintain the column of mercury at 40mm of mercury 
in  sphygmomanometer.  After  satisfactory  training,  continuous  electrocardiograph  is 
recorded during the maneuver for 10 to 20 seconds and immediately after the maneuver 
for 30 seconds.
Valsalva  ratio  is  obtained  by  dividing  longest  RR  interval  after  maneuver  to 
shortest RR interval during maneuver. 
PHASES OF VALSALVA MANEUVER1
         There is  a  sharp initial  rise  of  blood pressure equivalent  to the rise  in the 
intrathoracic pressure during the phase of forced expiration (phase1). 
         There after the pulse pressure diminishes gradually and the heart rate raises due to  
a fall in stroke out put (phase 2).
          On release of strain there is a sudden drop of blood pressure equivalent to the fall  
in intra thoracic pressure, and for a second or two pulse pressure may be small (phase 3). 
Rise in blood pressure can be seen if period of strain is long.
         With  restoration  of  normal  condition  the  heart  fills  properly  
and cardiac output increases. But before the pulse pressure widens the heart rate slows 
(vagal  stimulation)  due  to  reflex  vasoconstriction  initiated  by  small  pulse  pressure 
stimulating aortic and carotid baroreceptors (phase 4).
            Because of apparent value of this test, a bed side version was devised by Levin-
et-al. this is conveniently achieved by blowing up column of mercury and maintaining 
pressure of mercury column for ten seconds. Valsalva ratio is obtained by calculating 
ratio of maximum tachycardia to bradycardia.
        
2. Heart rate response to deep breathing
Page and walkins (1977)  found that in absence of autonomic symptoms, mean 
beat  to  beat  variation  is  slightly  impaired  perhaps  indicating  one  of  the  earliest 
manifestation of autonomic neuropathy. 
     Sinus arrhythmia is beat to beat variation of heart rate. This is controlled through 
autonomic nervous system. It is very often found in healthy children. In adult it becomes 
prominent after deep voluntary respiration. 
     During inspiration impulses arise from lungs which reflexly inhibit vagal tone, 
causing  increase  in  heart  rate.  It  can  be  quantified  and  used  as  a  bed  side  test  by 
measuring the difference between maximum and minimum heart rate during slow deep 
breathing (6 breaths per minute).since beat to beat variation is mediated by vagus, it is 
abolished or reduced in patients with autonomic neuropathy.  
Clinical Procedure
             Heart variation with deep breathing was recorded to the procedure by using 
electrocardiograph.  The  subject  lies  quietly  in  supine  position  and  is  connected  to 
electrocardiograph machine to record heart rate with lead 2. The patient is instructed to 
breath deeply at a rate of 6 breaths per minute a rate that produce maximum variation in 
heart rate, and simultaneous electrocardiograph recorded.           
      Heart  rate  was  compared  for  the  shortest  RR  interval  during  inspiration  and 
longest RR interval during expiration. Beat to beat variation is calculated by measuring 
the difference between the heart rates during inspiration and expiration.
3. Orthostatic variation of blood pressure
             It has long appreciated that postural hypotension is a sensitive indicator of 
autonomic dysfunction.  Berner (1952) has confirmed by experiments.  Friedman-et-al 
(1972) considering vasomotor tone studies in 19 patients defined postural hypotension 
as a fall of more than 30mm mercury in systolic pressure when the patient stand erect 
rapidly.
Clinical procedure
After 3 minutes of comfortable relaxation in supine position basal blood pressure 
is recorded over right arm. Three values are taken at intervals of one minute in between 
then the patient is asked to stand erect rapidly with in few seconds. Blood pressure is 
recorded. The cuff is completely deflated in between recordings
4. Heart rate response to standing
Change  from  horizontal  to  vertical  posture  produces  a  reflex  tachycardia 
maintained by autonomic nervous system Bennett (1976) concluded that sympathetic 
nervous system is intact if there is maintenance of blood pressure on standing associated 
with moderate tachycardia. Page-et-al observed that the peak rise in heart rate occurs 10 
to 20 seconds after standing up from supine position. Heart rate then stabilizes at a rate 
still higher than in supine position.
The peak rate increases varies but it is almost always greater than 15 beats per 
minute but in patients with autonomic neuropathy and improved cardiovascular reflexes, 
reflex tachycardia is diminished or lost in autonomic neuropathy.
Clinical procedure
Electrocardiograph is  first  recorded in  supine  position  and then the  subject  is 
asked to assume erect posture rapidly, electrocardiograph recording is being continued. 
Recording is done for 40 to 50 cardiac cycles  RR ratio is obtained by dividing the RR 
interval of 30th  beat to the RR interval of 15th  beat.
5. Blood pressure variation with sustained hand grip
 Sustained muscular exercise normally causes rise in heart rate, cardiac output and 
arterial  pressure.  This  response is  secondary  to rise  in  peripheral  vascular  resistance 
which is mediated by sympathetic and parasympathetic nervous system.
A simple test based on this reflex uses a hand grip dynamometer standardized at 
30% of maximum voluntary contraction with measurement  of  blood pressure during 
hand grip. Patients with autonomic neuropathy have an abnormal small diastolic blood 
pressure rise. Ewing defined the response of diastolic pressure rise of 16mm of mercury 
or above as normal, less than 10mm of mercury as abnormal.
Clinical procedure
Maximum  voluntary  contraction  is  determined  by  using  cuffed 
sphygmomanometer in place of hand grip dynamometer. 
          The  patient  lying in  supine position  blood pressure is  recorded.  A cuffed  
sphygmomanometer is inflated and the patient is asked to squeeze the cuff to that of 
mercury  column  of  sphygmomanometer  fixed  at  the  level  of  30  %  of  maximum 
voluntary contraction for 5 minutes. Blood pressure is recorded on the opposite arm at 
the end of 5 minutes.
        The response to hand grip test is measured as difference between the diastolic blood 
pressure at rest and the diastolic blood pressure before the release of grip. 
MATERIAL AND METHODS
Sixty patients with mean age of 57.7% who had non insulin dependent diabetes 
mellitus,  varying  from  one  year  to  fifteen  years  duration  with  normal  12  lead 
electrocardiograph were selected for study. 
 Clinical  signs  of  cardiac  failure  electrocardiograph  abnormalities  of  ischemia 
arrythmias were excluded from study. Those patients who had hypertension congestive 
cardiac failure ischemic heart disease chronic obstructive pulmonary disease and disease 
which  are  known  to  cause  autoimmune  dysfunction  rheumatoid  arthritis  leprosy, 
Gullian-barre syndrome etc were excluded from the study.
The diabetic control of the patient was achieved with diet, oral antidiabetic agents. 
The control group consisted of 10 nondiabetic individuals 6 males and 4 females 
with mean age of 50.1 % who fulfilled all the criteria and in addition had no family 
history of diabetes mellitus and no symptoms of autonomic dysfunction.
A detailed history physical examination and routine investigations were observed 
and recorded from all patients as set forth in the pro forma.
The following tests of autonomic function were carried out
Parasympathetic system
1) Heart rate variation to deep breathing
2) Postural variation of heart rate 
3) Valsalva test
Sympathetic system
4) Postural variation of blood pressure
5) Hand grip test
DISCUSSION
              A  study  of  involvement  of  autonomic  nervous  system  in  
60  patients  of  non  insulin  dependant  diabetes  mellitus  (with  age  less  than  fifty  19 
patients, 29 patients with age group 50 to 60, and 12 patients with age more than 60) and 
10 nondiabetic individuals control reveals the following.
             In 55% of the patients at least one symptoms of autonomic dysfunction was 
observed. 
POSTURAL GIDDINESS
The commonest symptom observed was Postural giddiness (33%) 20/60. 
Correlating  with  age,  10.5%  (2/19)  0f  patients  with  age  less  than  50  had 
postural giddiness. 
            In age group 50 to 60 postural giddiness was found in 31% (9/29)
            In patients with age more than 60, postural giddiness was found in 75% (9/12).
Correlating with duration of disease 
            Patients with duration of diabetes less than five years 12.5% (3/24) had postural  
giddiness.
            Patients with duration of diabetes in-between five to ten years 34.5% (10/29) had 
postural giddiness.
            Patients with duration of diabetes more than ten years 100% (7/7) had postural  
giddiness.
Sweating abnormality 
             The second commonest symptom observed was sweating abnormality (30%) 
18/60.
Correlating  with  age,  with  age  less  than  50  no  patients  had  sweating 
abnormality. 
In age group 50 to 60 sweating abnormality was found in 37.9% (11/29)
In patients with age more than 60, sweating abnormality was found in 58.3% 
(7/12).
Correlating with duration of disease 
            Patients with duration of diabetes less than five years 4% (1/24) had sweating 
abnormality.
            Patients with duration of diabetes in-between five to ten years 44.8% (13/29) had 
sweating abnormality.
            Patients with duration of diabetes more than ten years 57.1% (4/7) had sweating  
abnormality.
Nocturnal diarrhea and constipation 
             Nocturnal diarrhea and constipation was observed in 25% (15/60).
Correlating with age, 5% (1/19) 0f patients with age less than 50 had nocturnal 
diarrhea and constipation. 
            In age group 50 to 60 nocturnal diarrhea and constipation was found in 27.6% 
(8/29)
            In patients with age more than 60, nocturnal diarrhea and constipation was found 
in 50% (6/12).
Correlating with duration of disease 
            Patients with duration of diabetes less than five years no patient had nocturnal 
diarrhea and constipation.
            Patients with duration of diabetes in-between five to ten years 34.5% (10/29) had 
nocturnal diarrhea and constipation.
            Patients with duration of diabetes more than ten years 71.4% (5/7) had nocturnal 
diarrhea and constipation.
Postprandial fullness of stomach after 2 hours 
             Postprandial fullness of stomach after 2 hours was observed in 23.3% (14/60).
Correlating  with  age,  5%  (1/19)  0f  patients  with  age  less  than  50  had 
postprandial fullness of stomach after 2 hours. 
            In age group 50 to 60 postprandial fullness of stomach after 2 hours was found in 
24.1% (7/29)
            In patients with age more than 60, postprandial fullness of stomach after 2 hours 
was found in 50% (6/12).
Correlating with duration of disease 
            Patients with duration of diabetes less than five years 4% (1/24) had postprandial 
fullness of stomach after 2 hours. 
            Patients with duration of diabetes in-between five to ten years 31% (9/29) had 
postprandial fullness of stomach after 2 hours. 
            Patients with duration of  diabetes more than ten years 57.1% (4/7)  had 
postprandial fullness of stomach after 2 hours.  
Impotence 
           Impotence was reported in 13.3% (8/60).
Correlating with age, with age less than 50 no patient reported Impotence. 
            In age group 50 to 60 Impotence was reported in 13.8% (4/29)
            In patients with age more than 60, Impotence was reported in 33.3% (4/12).
Correlating with duration of disease 
            Patients with duration of diabetes less than five years no patient reported 
impotence.
            Patients with duration of diabetes in-between five to ten years 13.7% (4/29) had 
reported impotence
            Patients with duration of diabetes more than ten years 57.14% (4/7) had reported  
impotence.
Peripheral neuropathy and Pupilary changes
            Peripheral neuropathy was observed in 40% (24/60) of patients.
            In 46.6% (28/60) patients Pupilary changes was observed.
            In patients with peripheral neuropathy 95.8% (23/24) had Pupilary changes.
Resting tachycardia 
            Resting tachycardia was observed in 56.7% (34/60). 
Postural hypotension
             Postural hypotension was observed in 36.7% (22/60).
The  results  of  various  tests  of  autonomic  function  are  as  follows.  While 
interpreting the results all borderline cases were considered as normal.
Heart rate variation to deep breathing
Heart Rate (RR Interval) Variation during Deep Breathing
Normal > 15        Border line 10 – 15    Abnormal < 10
Mean of the Control Group 15.23
Mean of the Study Group 12.95
Mean of the Abnormal Group   6.94
The  mean 
rise  of  heart 
rate  during 
inspiration  in 
the  study 
group  was 
12.95  as 
against  15.23 
in  control 
group.
           Rise 
of  heart  rate 
less  than  ten 
was observed 
in  40%  of 
study  group 
with mean of 
6.94.    
S.No < 10 10 - 15 > 15
1 8.3 11.1 17.3
2 5.5 12.7 29.7
3 6.2 10.7 18.9
4 5.5 11.9 16.9
5 7.4 11.0 20.0
6 8.8 12.1 15.6
7 7.1 13.0 31.2
8 6.2 10.6 17.9
9 7.9 12.5 34.3
10 3.4 10.3 15.9
11 8.3 12.9 16.6
12 5.8 10.7 38.6
13 7.1 12.0 18.8
14 5.8 11.2 28.2
15 6.4 12.7 32.1
16 8.8 14.6 18.2
17 7.4 13.0
18 6.2 11.9
19 9.1 12.5
20 6.7 12.9
21 8.9
22 7.7
23 4.0
24 8.1
166.6 240.3 370.2
6.94 12.02 23.14
24/60 20/60 16/60
40 % 33.33 % 26.66 %
           Further 26.7% (16/60) had rise of heart rate in border line range 0f 10 to 15. 
II. Postural variation of heart rate 
                     Postural Variation of Heart Rate (30/15)
Normal > 1.03      Border line 1.0 – 1.03  Abnormal < 1.0
Mean of the Control Group 1.06
Mean of the Study Group 1.02
Mean of the Abnormal Group 0.901
S.No < 1.00 1.00 - 1.03 > 1.03
1 0.960 1.023 1.360
2 0.820 1.030 1.200
3 0.930 1.000 1.680
4 0.890 1.027 1.150
5 0.870 1.025 1.070
6 0.920 1.030 1.200
7 0.960 1.024 1.300
8 0.940 1.029 1.350
9 0.920 1.026 1.380
10 0.880 1.023 1.060
11 0.830 1.027 1.280
12 0.930 1.025 1.330
13 0.890 1.029 1.100
14 0.970 1.000 1.480
15 0.950 1.024 1.220
16 0.947 1.030 1.160
17 0.830 1.026 1.230
18 0.800 1.023 1.110
19 0.830 1.600
20 0.950 1.080
21 1.460
22 1.260
 18.017 18.421 28.060
 0.901 1.023 1.275
The mean value of 30/50 ratio was 1.02 in the study group is compared to 1.06 in 
control group.
In study group 33.3% (20/60) had 30/15 ratio less than one with mean 0.901.
Further 30% (18/60) of patient in study group had 30/15 ratio in borderline range 
of 1.00 to 1.03.
III.  Valsalva test
Valsalva Ratio
Normal  > 1.2      Border line 1.11 – 1.2     Abnormal < 1.11
Mean of the Control Group 1.25
Mean of the Study Group 1.189
Mean of the Abnormal Group 0.997
S.No < 1.11 1.11 - 1.20 > 1.20
1 1.080 1.130 1.310
2 1.040 1.190 1.310
3 1.100 1.120 1.480
4 1.000 1.150 1.260
5 0.890 1.130 1.260
6 0.920 1.140 1.380
7 1.074 1.160 1.310
8 0.950 1.185 1.320
9 1.100 1.192 1.310
10 0.960 1.115 1.460
11 0.930 1.125 1.280
12 1.070 1.160 1.430
13 0.890 1.130 1.230
14 1.027 1.140 1.350
15 0.940 1.111 1.430
16 1.030 1.192 1.240
17 1.000 1.330
18 0.950 1.480
19 1.380
20 1.310
21 1.480
22 1.310
23 1.350
24 1.460
25 1.330
26 1.230
 17.951 18.370 35.020
 0.997 1.148 1.347
The mean value of Valsalva ratio was 1.189 in the study group is compared to 
1.256 in control group.
In study group 30% (18/60) with mean 0.997 had Valsalva ratio less than 1.11.
Further 26.7% (16/60) of patient in study group had Valsalva ratio in borderline 
range of 1.22 to 1.2.
IV.  Postural variation of blood pressure
Postural hypotension
Fall in systolic blood pressure 
                Normal <= 10 mm/Hg   
                Border line 11-29 mm/Hg   
                Abnormal >= 30 mm/Hg
Mean of the Control Group -9.8 mm/Hg
Mean of the Study Group          -20.86 mm/Hg
Mean of the Abnormal Group -34 mm/Hg
S.No >= 30 11 - 29 <= 10
1 -30 -24 -10
2 -36 -18 -8
3 -38 -12 -6
4 -36 -20 -8
5 -34 20 -6
6 -38 -18 -10
7 -40 -16 -10
8 -32 -12 -6
9 -32 -20 -10
10 -30 -14 -8
11 -38 -16 -10
12 -34 -12 -6
13 -30 -18  
14 -36 -20  
15 -38 -14  
16 -36 -18  
17 -34 -24  
18 -32 -16  
19 -34 -18  
20 -30 -12  
21 -36 -16  
22 -32 -14  
23  -20  
24  -18  
25  -12  
26  -16  
 -756 -398 -98
 -34 -15 -8
In the study the mean fall of blood pressure on standing was -20.86 millimeter of 
mercury as compared to 9.8 millimeter of mercury in control group.
Among the patients 36.7% (22/60) had fall  in blood pressure of more than 30 
millimeter of mercury.
Further 26.7% (26/60) of patient in study group had borderline fall between 11 
and 29 millimeter of mercury. 
               
V.  Hand grip test
Blood pressure response to sustained hand grip
Normal<= 10     Border line 11-16     Abnormal >= 16
          Mean of the Control Group 16.4
          Mean of the Study Group              11.7
          Mean of the Abnormal Group 8.14
S.No <= 10 11 - 16 >= 16
1 6 14 16
2 10 12 18
3 8 14 16
4 6 12 16
5 10 12 18
6 10 14 16
7 6 14 16
8 6 14 18
9 8 12 18
10 10 14 16
11 8 12 16
12 8 12 16
13 10 14 18
14 6 14 16
15 10 12
16 10 12
17 8 14
18 6 12
19 10
20 6
21 6
22 10
23 8
24 10
25 6
26 8
27 8
28 10
 228 234 234
 8.143 13 16.714
The mean rise in diastolic blood pressure in study group was 8.14 as compared to 
16.4 in control group.
           Among the patients 46.7% (28/60) had rise of blood pressure less than 10 
millimeter of mercury.
           Further 23.3% (14/60) had borderline rise of blood pressure between 10 and 16 
millimeter of mercury.
Control group:
Control Group
S.No
Hand 
Grip 
Test
BP 
Variation 
of HR
Postural 
Variation 
of HR
Valsalva 
Ratio
Postural 
Variation 
Of BP
1 16 13.80 1.14 1.38 -6.0
2 18 10.50 1.06 1.20 -4.0
3 16 17.20 1.10 1.12 -12.0
4 18 17.40 1.00 1.43 -16.0
5 14 23.80 1.04 1.20 -8.0
6 16 11.20 1.10 1.14 -12.0
7 16 18.20 1.05 1.25 -12.0
8 18 17.40 1.00 1.18 -16.0
9 14 10.50 1.04 1.53 -4.0
10 18 12.30 1.10 1.13 -8.0
 164 152.30 10.63 12.56 -98.0
 16.4 15.23 1.06 1.256 -9.8
CONCLUSION
The exact prevalence of autonomic neuropathy in diabetes is precisely not known, 
however tests of autonomic function have shown impairment in roughly 40 to 50% of 
diabetic patients.
Subclinical autonomic nerve damage occurs more widely in diabetes and may go 
unnoticed. It is assuming greater importance because of the implications for morbidity 
and mortality.
Symptomatic  autonomic  neuropathy  carries  worse  prognosis  than  any  other 
complication of diabetes.
Prevention of autonomic damage with newer drugs, particularly in its earlier stage 
will reduce the mortality and morbidity significantly.
Newer  drugs  have  to  be  tried  for  comforting  many  diabetics  with  clinical 
autonomic neuropathy afflicted with this condition in that atleast the quality of life of 
with diabetic neuropathy will improve.
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PROFORMA
STUDY OF CLINICAL PRESENTATION OF AUTONOMIC NEUROPATHY IN 
PATIENTS WITH DIABETES MELLITUS
Name :
Age    :                             Sex :  IP / OP. No. :
Clinical Data:   Diabetes mellitus 
Duration of diabetes
History
 Polyuria
 Polydipsia
 Polyphagia
 Weight loss
 Fatigue
 Skin infection              
 Periarthritis shoulder           
 Balanitis/ pruritis vulva
Clinical data:   Autonomic neuropathy
 Persistent fullness of stomach 2 hours after meals
 Nocturnal diarrhea 
 Constipation
 Bladder distension
 Post void residual urine
 Erectile dysfunction
 Light headedness on standing
 Syncope on standing
 Postprandial  hyperhydrosis  of  upper  extremitie  and  anhydrosis  of  lower 
extremities
Clinical data:   Peripheral Neuropathy
 Numbness
 Paresthesias
 Hyperesthesia
Past history
 Hypertension     
 Ischemic heart disease       
 STD
 Prostate enlargement 
 Urethral stricture
Treatment history
 Oral hypoglycemic agents                    
 Insulin
Family history
General examination
 Pallor                  
 Icterus                    
 Cyanosis   
 Clubbing         
 Lymphadenopathy           
 Edema
Vital data
 Pulse
Lying 
Standing
 Blood pressure 
Lying
Standing
• Respiratory rate
 Temperature
Cardiovascular system
 Jugular venous pressure
 Heart sounds
 Murmur
Respiratory system
 Breath sounds
 Added sounds
Abdomen
 Bowel sounds
 Free fluid
 Liver/spleen
Nervous system
 Peripheral neuropathy
 Any focal neurological deficit
Pupil 
 Size                        
 Shape    
Light reflex
 Accommodation                   
Tests for Autonomic neuropathy
A. Heart rate variation to deep breathing
B. Postural variation of heart rate 
(RR interval of 30thbeat/15thbeat)
C. Valsalva test
(Longest RR interval after maneuver/shortest RR interval during maneuver)
D. Postural variation of blood pressure
Supine BP (3 min rest) to BP immediately in erect posture
E. Hand grip test (diastolic blood pressure variation > 16mm)
(30 % of maximum voluntary contraction for 5 min)
